ArticleFrontiers in genetics2022
Sampling and ranking spatial transcriptomics data embeddings to identify tissue architecture.
Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging AI approaches for cancer spatial omics.GigaScience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spatial transcriptomics is an emerging technology widely applied to the analyses of tissue architecture and corresponding biological functions. Substantial computational methods have been developed for analyzing spatial transcriptomics data. These methods generate embeddings from gene expression and spatial locations for spot clustering or tissue architecture segmentation. Although the hyperparameters used to produce an embedding can be tuned for a given training set, a fixed embedding has variable performance from case to case due to data distributions. Therefore, selecting an effective embedding for new data in advance would be useful. For this purpose, we developed an embedding evaluation method named message passing-Moran's I with maximum filtering (MP-MIM), which combines message passing-based embedding transformation with spatial autocorrelation analysis. We applied a graph convolution to aggregate spatial transcriptomics data and employed global Moran's I to measure spatial autocorrelation and select the most effective embedding to infer tissue architecture. Sixteen spatial transcriptomics samples generated from the human brain were used to validate our method. The results show that MP-MIM can accurately identify high-quality embeddings that produce a high correlation between the predicted tissue architecture and the ground truth. Overall, our study provides a novel method to select embeddings for new test data and enhance the usability of deep learning tools for spatial transcriptome analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.